# The 14 Research Tracks

BioOncoGraph v2.0 is meticulously structured to support specific domains within oncology. We have identified and optimized the framework for **14 distinct research tracks**. Each track provides specialized datasets, model architectures, and evaluation metrics.

## Track Overview

### 1. Drug-Target Interaction (DTI)
Predicting novel interactions between chemical compounds and protein targets. Crucial for drug repurposing and discovering new therapeutics.
*   **Key Models**: Heterogeneous Graph Transformers (HGT), Interaction-aware GCNs.
*   **Primary Metrics**: AUPRC, Hits@K.

### 2. Drug Response Prediction (DRP)
Predicting how a specific cell line or patient will respond (e.g., IC50, AUC) to a particular drug based on their multi-omics profile.
*   **Key Models**: Graph Regression Models, Multimodal Fusion Encoders.
*   **Primary Metrics**: RMSE, Pearson Correlation.

### 3. Synergistic Drug Combinations
Identifying pairs or combinations of drugs that exhibit synergistic effects when used together, overcoming resistance.
*   **Key Models**: Higher-order Link Prediction, Tensor Factorization on Graphs.

### 4. Biomarker Discovery
Identifying specific genes, proteins, or pathways that indicate the presence of cancer, its progression, or response to therapy.
*   **Key Models**: Node Classification, Subgraph Explainer models for interpretability.

### 5. Patient Stratification
Clustering patients into distinct subgroups based on molecular and clinical profiles to tailor personalized treatment plans.
*   **Key Models**: Unsupervised Graph Clustering, Graph Autoencoders.

### 6. Adverse Drug Reaction (ADR) Prediction
Predicting potential side effects or toxicities of oncology drugs using structural and biological network data.
*   **Key Models**: Multi-relational Link Prediction (Polypharmacy).

### 7. Gene-Disease Association
Uncovering novel links between specific gene mutations or expressions and cancer subtypes.
*   **Key Models**: Random Walk with Restart (RWR) on heterogeneous networks, TransE variants.

### 8. Pathway Analysis and Crosstalk
Modeling signaling pathways and identifying critical crosstalk mechanisms that drive tumor growth or resistance.
*   **Key Models**: Directed Graph Neural Networks, Motif Discovery.

### 9. Neoantigen Prediction
Predicting which mutated peptides will be presented by MHC molecules and recognized by the immune system, essential for cancer vaccines.
*   **Key Models**: Sequence-to-Graph models, 3D structural GNNs.

### 10. Spatial Transcriptomics Modeling
Integrating spatial information with single-cell RNA sequencing data to understand the tumor microenvironment.
*   **Key Models**: Spatial Graph Convolutions, Graph Attention Networks.

### 11. Clinical Trial Matching
Matching patient profiles to inclusion/exclusion criteria of active clinical trials using graph-based knowledge retrieval.
*   **Key Models**: LLM-GNN integration, Knowledge Graph Question Answering (KGQA).

### 12. Resistance Mechanism Prediction
Identifying pathways or mutations that emerge to confer resistance to a given therapy.
*   **Key Models**: Dynamic Graph Neural Networks, Temporal modeling.

### 13. Multi-omics Integration
A general track for developing novel methods to seamlessly fuse genomic, transcriptomic, proteomic, and epigenomic data.
*   **Key Models**: Multiplex Graph Networks, Cross-attention mechanisms.

### 14. Target Druggability Assessment
Predicting whether a novel protein target can be effectively modulated by a small molecule or biologic.
*   **Key Models**: Protein Structure GNNs, Pocket prediction models.

## Using a Specific Track

To utilize resources for a specific track, use the `biooncograph.apps` module.

```python
from biooncograph.apps import DTIApp

# Initialize the DTI application
app = DTIApp(workspace='./dti_workspace')

# Load track-specific default dataset and model
app.load_default_data()
app.build_model()
app.train()
```
